We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ALGBE market cap is 32.43M. The company's latest EPS is EUR -0.6608 and P/E is -2.71.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.77M | 3.49M | 3.28M | 3.13M | 1.8M |
| Operating Income | -15.67M | -13.9M | -13.06M | -12.45M | -11.92M |
| Net Income | -13.64M | -12.74M | -11.15M | -11.77M | -11.99M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 25.44M | 27.95M | 25.8M | 31.79M | 21.58M |
| Total Liabilities | 19.16M | 18.24M | 21.67M | 13.12M | 13.93M |
| Total Equity | 6.28M | 9.71M | 4.13M | 18.66M | 7.65M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -7.42M | -10.27M | -10.68M | -11.88M | -10.15M |
| Investing | -973k | -240k | -607k | -2.49M | -1.93M |
| Financing | 5.26M | 17.18M | 9.48M | 21.14M | -135k |
| Market Cap | 32.43M |
| Price to Earnings Ratio | -2.71 |
| Price to Sales Ratio | 18.06 |
| Price to Cash Ratio | 3.7 |
| Price to Book Ratio | 4.25 |
| Dividend Yield | - |
| Shares Outstanding | 18.14M |
| Average Volume (1 week) | 28.7k |
| Average Volume (1 Month) | 26.26k |
| 52 Week Change | -14.65% |
| 52 Week High | 4.37 |
| 52 Week Low | 1.702 |
| Spread (Intraday) | 0.02 (1%) |
| Company Name | Global Bioenergies |
| Address |
5 rue henri desbrueres evry, essonne 91000 |
| Website | https://www.global-bioenergies.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
